NCORP of the Carolinas (Greenville Health System NCORP)

描述(由申请人提供)：卡罗莱纳州NCORP的目标是：1.每年至少招募300名患者参加NCI临床试验网络(NCTN)试验，包括癌症预防、控制、筛查/治疗后监测、治疗和成像临床试验。2.提供社区意见，并协助NCTN研究基地开展治疗、预防、控制和筛查、与健康相关的生活质量和癌症护理提供研究(CCDR)。3.达到协议合规性并提交准确、及时的数据。4.开展研究，办法是让社区参与，包括少数群体和未得到充分服务的群体，并向社区通报通过研究取得的进展。5.在癌症护理服务研究(CCDR)领域成长为全国领先者。卡罗莱纳州的NCORP将执行由NCTN集团赞助的每个阶段的临床试验研究，包括通过ITOR(翻译肿瘤研究所)包括基于基因测序的翻译治疗。GHS临床数据仓库系统将为CCDR提供数据。格林维尔卫生系统(GHS)癌症研究所参与了一个已经很强大的生物谱系信息库，并加入了癌症基因组计划(2013年7月接受赠款)，总体而言，卡罗莱纳州NCORP的组成部分和子组成部分是致力于治疗、预防、支持性护理和系统管理的组织，以实现研究成果。卡罗莱纳州的NCORP将最大限度地提高其研究能力，以确保在癌症预防、诊断、治疗和护理/护理提供方面取得最高质量的进展。

DESCRIPTION (provided by applicant): The goals of NCORP of the Carolinas are 1. To enroll a minimum of 300 patients annually to NCI Clinical Trials Network (NCTN) trials including cancer prevention, control, screening/post-treatment surveillance, treatment, and imaging clinical trials. 2. To provide community input and assist the NCTN research bases in develop treatment, prevention, control and screening, health related quality of life and cancer care delivery research (CCDR). 3. To attain protocol compliance and submit accurate, timely data. 4. To conduct research by engaging the community, inclusive of minorities and the underserved, and informing the community of advances made through research. 5. To grow as a national leader in the realm of Cancer Care delivery research (CCDR). NCORP of the Carolinas will be perform every phase of clinical trial research sponsored by NCTN groups, including to include, via ITOR (Institution of Translational Oncology Research), translational treatment based on genetic sequencing. GHS Clinical data warehouse system will provide data for CCDR. The Greenville Health System (GHS) Cancer Institute participates in an already robust biospecimen repository and entered membership in the Cancer Genome project (grant accepted July 2013) Collectively the components and sub-components of NCORP of the Carolinas are organizations dedicated to treatment, prevention, supportive care, and system management for study accrual. NCORP of the Carolinas will maximize its research capabilities to ensure progress towards the highest quality of cancer prevention, diagnosis, treatment and care/care delivery.